|
|
||||||||
a Division of Cardiovascular Surgery, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania
b Division of Hematology and Oncology, Pennsylvania Hospital, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania
c Division of Cardiovascular Medicine, Pennsylvania Hospital, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania
d Department of Thoracic and Cardiovascular Surgery, Sanger Heart and Vascular Institute, Carolinas Healthcare System, Charlotte, North Carolina
Accepted for publication June 14, 2011.
* Address correspondence to Dr Bridges, Department of Thoracic and Cardiovascular Surgery, Sanger Heart and Vascular Institute, Carolinas Healthcare System, 1001 Blythe Blvd, Ste 300, Charlotte, NC 28203 (Email: charles.bridges{at}carolinashealthcare.org).
Background: Cardiac surgery in Jehovah's Witnesses poses unique challenges. We have developed a comprehensive multimodality program for these patients and have obtained excellent results.
Methods: Ninety-one Jehovah's Witness patients underwent cardiac surgery between 2000 and 2010. Preoperative, intraoperative, and postoperative considerations in the conduct of bloodless surgery in the Jehovah's Witness population are discussed. Mortality for isolated coronary artery bypass graft surgery and isolated aortic valve replacement was compared with predicted mortality from The Society of Thoracic Surgeons (STS) risk models. Perioperative outcomes were stratified by urgent and elective status of operations.
Results: Mean age was 65 ± 12.4 years. Comorbid conditions included hypertension (84.6%), diabetes mellitus (48.4%), previous myocardial infarction (23.1%), chronic lung disease (38.5%), peripheral vascular disease (20.9%), and renal failure (11%). In-hospital mortality was 5.5% (n = 5). Mortality for isolated coronary artery bypass graft surgery and isolated aortic valve replacement was 2.2% (observed to expected ratio = 1.05, 95% confidence interval: 0 to 3.02) and 5.6% (observed to expected = 1.46, 95% confidence interval: 0 to 3.76), respectively. Other complications included reoperation (all = 8.8%, cardiac = 2.2%), sepsis (2.2%), sternal wound infection (1.1%), transient ischemic attack (1.1%), renal failure requiring dialysis (1.1%), and prolonged ventilation (18.7%). Major complication rates were not significantly different between the elective group and the urgent group.
Conclusions: Bloodless cardiac surgery in Jehovah's Witness patients can be performed with excellent outcomes in both elective and urgent situations. Mortality rates for isolated coronary artery bypass graft surgery and isolated aortic valve replacement are within the expected 95% confidence intervals of STS predicted mortality.
Related Article
Ann. Thorac. Surg. 2012 93: 25.
This article has been cited by other articles:
![]() |
V. A. Ferraris, S. P. Saha, J. H. Oestreich, H. K. Song, T. Rosengart, T. B. Reece, C. D. Mazer, C. R. Bridges, G. J. Despotis, K. Jointer, et al. 2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations Ann. Thorac. Surg., November 1, 2012; 94(5): 1761 - 1781. [Full Text] [PDF] |
||||
![]() |
A. Polat, E. B. Polat, and N. Kayalar Perioperative Acute Kidney Injury After Cardiac Surgery Ann. Thorac. Surg., November 1, 2012; 94(5): 1785 - 1786. [Full Text] [PDF] |
||||
![]() |
E. Elmistekawy, T. G. Mesana, and M. Ruel Should Jehovah's Witness patients be listed for heart transplantation? Interact CardioVasc Thorac Surg, October 1, 2012; 15(4): 716 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Carpenter Invited Commentary Ann. Thorac. Surg., January 1, 2012; 93(1): 25 - 25. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |